SINTX Technologies Inc SINT
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SINT is a good fit for your portfolio.
News
-
SINTX Technologies Announces Pricing of $1.5 Million Public Offering of Common Stock
-
SINTX Technologies Announces Proposed Public Offering of Common Stock
-
SINTX Technologies Announces Pricing of $1.3 Million Public Offering of Common Stock
-
SINTX Technologies Announces Proposed Public Offering of Common Stock
-
SINTX TECHNOLOGIES ENTERS INTO A SECOND LONG TERM SUPPLY AGREEMENT FOR THE AEROSPACE MARKET
-
SINTX Technologies Announces Closing of $4.0 Million Public Offering
-
SINTX Technologies Announces Pricing of $4.0 Million Public Offering
-
SINTX SUBSIDIARY TECHNOLOGY ASSESSMENT & TRANSFER TO DEVELOP 3D PRINTING AND CMCs WITH DEVCOM-ARMY RESEARCH LABORATORY
Trading Information
- Previous Close Price
- $0.04
- Day Range
- $0.03–0.05
- 52-Week Range
- $0.02–2.13
- Bid/Ask
- $0.04 / $0.04
- Market Cap
- $5.13 Mil
- Volume/Avg
- 109.9 Mil / 28.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
SINTX Technologies Inc is an advanced ceramics company, focused on providing solutions in a variety of biomedical, technical, and antipathogenic applications. It has grown from focusing primarily on the research, development, and commercialization of medical devices manufactured with silicon nitride to becoming an advanced ceramics company engaged in diverse fields, including biomedical, technical, and antipathogenic applications. Its biomedical products are biocompatible, bioactive, antipathogenic, and to have superb bone affinity. Spinal implants made from SINTX silicon nitride have been successfully implanted in humans in the US, Europe, Brazil, and Taiwan.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 41
- Website
- https://www.sintx.com
Valuation
|
Metric
|
SINT
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.02 |
Price/Sales | 0.14 |
Price/Cash Flow | — |
Price/Earnings
SINT
Financial Strength
|
Metric
|
SINT
|
|---|---|
Quick Ratio | 1.39 |
Current Ratio | 1.90 |
Interest Coverage | −4,196.00 |
Quick Ratio
SINT
Profitability
|
Metric
|
SINT
|
|---|---|
Return on Assets (Normalized) | −77.51% |
Return on Equity (Normalized) | −124.75% |
Return on Invested Capital (Normalized) | −100.79% |
Return on Assets
SINT
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Tnxhngjng | Fwqrg | $182.7 Bil | |
SYK
| Stryker Corp | Jmxmbqymg | Wjn | $124.6 Bil | |
MDT
| Medtronic PLC | Qlpvvnlg | Xgpxcfg | $105.2 Bil | |
BSX
| Boston Scientific Corp | Zszybthmj | Xcggt | $99.1 Bil | |
EW
| Edwards Lifesciences Corp | Sklyvhwlg | Tdndf | $52.0 Bil | |
DXCM
| DexCom Inc | Nypgsnyx | Zys | $51.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qwqxlwdrvk | Vps | $24.5 Bil | |
ALGN
| Align Technology Inc | Tjprrmt | Mhkhff | $22.7 Bil | |
PHG
| Koninklijke Philips NV ADR | Ncqfkbyh | Rhnwb | $18.3 Bil | |
PODD
| Insulet Corp | Sgwmkzqvd | Ddfhsg | $11.6 Bil |